- Pharmanovia acquires 11 CNS brands, including Frisium® (clobazam) and Gardenal® (phenobarbital) - The portfolio is available in more than 60 mar...
Positive opinion based on Phase 3 ADAPT-SC study demonstrating noninferior total IgG reduction at day 29 with subcutaneously (SC) administered efgartigim...
Olink Holding AB (publ) (“Olink”) (Nasdaq: OLK) today announced the collaboration with Eurofins Genomics to bolster its offerings in the fields...
Uniting the Global Supply Chain: CPHI Barcelona serves as a vital platform for unrivalled networks and access to the global supply chain. It provides unpa...
The aim of the LOVE-DEB Study (Large de-NOVo coronary artEry disease treated with sirolimus Drug Eluting Balloon: prospective evaluation of safety & ef...
Peanut allergy currently affects approximately 2% of the general population of Western nations1, and the prevalence of peanut allergy doubled among childre...
Novozymes and the Danish industrial biotech company, Bactolife, have signed a joint development and commercialization agreement to finish development and l...
The 12-month Venture Lab program is designed to support start-up companies with business acceleration, scientific, and team development, and provides a fou...
SpendEdge, a global leader in procurement market intelligence space recently connected with a large Europe-based pharma company focused on large and small ...
The updated COVID-19 vaccine is tailored to the Omicron XBB.1.5 sublineage of SARS-CoV-2 and is recommended for individuals 6 months of age a...
After being in stealth mode for a year, Elastin Biosciences, an innovative biotech company spun off from Longaeuvus Technologies, has unveiled a groundbrea...
Next-generation laser vision correction provides next-day results and recovery1,2 The next-generation ELITATM Fe...
Evrysdi available to treat people of all ages with SMA in the European Union, including babies from birth1 Approval is based on interim data from ongoin...
These models are essential for testing in vivo efficacy of novel therapeutics against lung cancer, elevating the prospects for significant advances in the ...
© 2026 Biopharma Boardroom. All Rights Reserved.
